SUBSCRIBE TO MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

THE INTERACTIVE GUIDE


Click here to read the MM&M 2013 Game Changers issue, with a report on trends that are changing the industry and a showcase of companies at the forefront of this transition.

2011/12 Pharmaceutical Marketers Directory


NOW FULLY
SEARCHABLE ONLINE
UPDATED MONTHLY @ ThePMD.com
Over 6,000 new names, and 20,000 business connections. From the industry's trusted resource for over 34 years. Now find what you need even quicker and easier with the searchable online edition.

Get connected today and order your personal copy and free online access!

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Since Vioxx scare, tough times for industry R&D, study finds

A review of 450 New Molecular Entities spanning a decade and a half found two distinct eras of drug R&D - one of abundance and one of scarcity, hinging on the September, 2004 withdrawal of Merck's Vioxx.
 

GSW's Gerbig dead at 66; put Columbus on the map for medical advertising

GSW Worldwide co-founder Bob Gerbig, an entrepreneurial account director who left Abbott to launch the Ohio-based agency powerhouse in 1977, has died at 66.
 

Senators slam Pfizer-PBM deal to blunt generic Lipitor

Pfizer's Lipitor had not yet gone off patent before a trio of Senate healthcare heavyweights was firing off letters to the drugmaker assailing its efforts to conserve Lipitor share through a deal with pharmaceutical benefit managers.
 



Why is Regional Marketing So Hot? Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence.

In Brief

Company news: Pfizer and Bristol-Myers Squibb

The FDA granted priority review status to Eliquis (apixaban), the novel oral anticoagulant being developed by Pfizer and Bristol-Myers Squibb.
 

LATEST FEATURES

Pharma Sales Report: Special Force

Seeking part of the primary care market, specialty and biotech firms are filling the void being left by Big Pharma. Marc Iskowitz on the strategies and tactics for engaging customers and maximizing sales budgets
 

What agencies and clients want

As pressure mounts on the industry, it's more important to make the agency-client relationship work. James Chase and Marc Iskowitz ask agency leaders and pharma marketers what they want from each other
 

Headliner: Helping companies and patients

Manny Hernandez, the founder of Diabetes Hands Foundation, has partnered with pharma companies on education and support programs
 

Private View

Unbranded campaigns provide an effective approach to creating a meaningful disruption in the marketplace, and give your agency another outlet to showcase its strategic, scientific, and creative prowess.
 

MM&M Awards 2011

Almost 700 of the industry's brightest stars came to New York's Cipriani 42nd Street for the sold-out MM&M Awards 2011 dinner and ceremony, at which the gold and silver winners in 23 categories were revealed.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.